Status:
TERMINATED
Vaccine Observation to Include All Communities for Equitable Science
Lead Sponsor:
Persephone Biosciences
Conditions:
Vaccine Response Impaired
Vaccine Adverse Reaction
Eligibility:
All Genders
18+ years
Brief Summary
VOICES is a longitudinal, prospective, observational study that will enroll up to 10,000 subjects of diverse racial backgrounds being administered an emergency use authorized COVID-19 vaccine, for col...
Eligibility Criteria
Inclusion
- Men or women who are ≥ 18 years old and expecting to receive the SARS-CoV-2 vaccine within the next 30 days.
- Subjects who are able to provide written informed consent.
Exclusion
- Subjects with known HIV, Hepatitis A, Hepatitis B, Hepatitis C, or SARS-CoV-2 infection within 4 weeks of vaccination
- Subjects without the mental capacity to complete either a written or online questionnaire, alone or with assistance, or make sound decisions
- Women who are pregnant, plan on becoming pregnant, or are nursing.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04770649
Start Date
April 1 2021
End Date
December 31 2022
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Persephone Biosciences, Inc.
San Diego, California, United States, 92121